HORIBA Exhibits Compact Benchtop Hematology Analyzers
|
By LabMedica International staff writers Posted on 03 Feb 2025 |
|
Image: The Yumizen H550 and H500 are compact benchtop hematology analyzers with enhanced performance (Photo courtesy of HORIBA)
HORIBA (Kyoto, Japan) is presenting its latest IVD solutions at Medlab Middle East 2025, including the Yumizen H550 and H500 hematology analyzers.
The HORIBA Medical Segment designs, develops, and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics, and university hospitals. HORIBA’s expertise in vitro diagnostics is one of the most respected in hematology worldwide. The new generation of HORIBA’s automated hematology analyzer offers solid and reliable diagnostic technology as well as rapid and consistent results. HORIBA provides a wide range of hematology analyzers and automated instruments to realize blood analysis (blood cell identification and counting) for the diagnosis of various blood-related diseases. These instruments are designed for all kinds of laboratories, from small laboratories (to 150 patients a day), to larger ones (more than 2000 patients a day). These efficient and reliable instruments feature automated racks, data management, and quality tools providing a complete solution for meeting high-quality medical analysis requirements.
The new Yumizen H500 and H550 compact benchtop hematology analyzers featured at Medlab Middle East 2025 deliver enhanced performance, new features, and increased benefits. Both analyzers come with optional infectious flags for malaria and dengue, making them ideal for small labs to meet a variety of clinical lab environments and settings such as routine hematology, satellite labs, oncology care, and blood banks. HORIBA is also highlighting HELO 2.0, an innovative solution covering all the needs of a high throughput automated hematology platform. Flexible and efficient, HELO 2.0 is the optimum answer to the constant evolution of laboratories. Thanks to its data, tube management, waste, blood film, and digitalization management capability, HELO 2.0 not only fulfills all the needs of laboratories but also helps optimize their TAT, floor space, and reagent storage.
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Automatic CLIA Analyzer
Shine i9000
Urine Chemistry Control
Dropper Urine Chemistry Control
Latest MEDLAB 2025 News
- Medlab Middle East Rebranded to WHX Labs Dubai
- BIOBASE Showcases Comprehensive Range of Laboratory Solutions
- Dymind Presents Advanced Automatic Hematology Analysis Line
- BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis
- YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency
- Vazyme Showcases Cutting-Edge Microfluidic Solutions for Precise and Efficient Laboratory Workflows
- Erba Unveils New H 7100 Advanced Hematology Analyzer
- HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
- Tianlong Presents Advanced Instruments and Cutting-Edge Reagents
- Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes
- DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel
- Fapon Presents Comprehensive Range of One-Stop IVD Solutions
- Anbio Biotechnology Showcases Cutting-Edge Diagnostic Solutions
- Sysmex Showcases Latest Laboratory Innovations and Technologies
- Sansure Presents Advanced Diagnostic Solutions
- Snibe Demonstrates Cutting-Edge Diagnostic Solutions
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more